Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by alleyesonmeon Nov 30, 2022 12:21am
332 Views
Post# 35138681

Pizer partnership?

Pizer partnership?Despite spending billions for arena pharmaceuticals who holds a secret cannabinoid pipeline Pizer doesn't produce cannabinoid API's nor do they hold licensing or cannabinoid drug masterfile's needed for new drug applications or Abbreviated new drug applications. They need a partner. As aforementioned CBD is a FDA approved pharmaceutical called EPIDIOLEX therefore if a pharmaceutical company were to commercialize CBD/Canabidol/for a new treatment from a completed successful trial they would apply for an abbreviated new drug application and it's abbreviated because epidiolex is fda approved and is 95% pure natural CBD therefore not new but for a new treatment/ailment.  To QF's(ED's) credit...PIZER is a global pharmaceutical company who's invested billions in cannabinoid pharmaceuticals and have yet to release one....and do not have API capacity/ability meaning they need a partner....medipharm labs has announced we have a global pharmaceutical partner who has used medipharms DMF masterfile in a abbreviated new drug application...hmm..likely partnership?...
<< Previous
Bullboard Posts
Next >>